10.6084/m9.figshare.5324977.v1
Salhofer-Polanyi S.
Salhofer-Polanyi
S.
Cetin H.
Cetin
H.
Leutmezer F.
Leutmezer
F.
Baumgartner A.
Baumgartner
A.
Blechinger S.
Blechinger
S.
Dal-Bianco A.
Dal-Bianco
A.
Altmann P.
Altmann
P.
Bajer-Kornek B.
Bajer-Kornek
B.
Rommer P.
Rommer
P.
Guger M.
Guger
M.
Leitner-Bohn D.
Leitner-Bohn
D.
Reichardt B.
Reichardt
B.
Alasti F.
Alasti
F.
Temsch W.
Temsch
W.
Stamm T.
Stamm
T.
Supplementary Material for: Epidemiology of Multiple Sclerosis in Austria
Karger Publishers
2017
Epidemiology
Multiple sclerosis
Austria
2017-08-18 09:45:10
Journal contribution
https://karger.figshare.com/articles/journal_contribution/Supplementary_Material_for_Epidemiology_of_Multiple_Sclerosis_in_Austria/5324977
<p><b><i>Background:</i></b> To assess the incidence rate and prevalence ratio of multiple sclerosis (MS) in Austria. <b><i>Methods:</i></b>
Hospital discharge diagnosis and MS-specific immunomodulatory treatment
prescriptions from public health insurances, covering 98% of Austrian
citizens with health insurance were used to extrapolate incidence and
prevalence numbers based on the capture-recapture method. <b><i>Results:</i></b>
A total of 1,392,629 medication prescriptions and 40,956
hospitalizations were extracted from 2 data sources, leading to a total
of 13,205 patients. The incidence rate and prevalence ratio of MS in
Austria based on the capture-recapture method were 19.5/100,000
person-years (95% CI 14.3-24.7) and 158.9/100,000 (95% CI 141.2-175.9),
respectively. Female to male ratio was 1.6 for incidence and 2.2 for
prevalence. <b><i>Conclusions:</i></b> Incidence rates and prevalence
ratios of MS in our study are within the upper range of comparable
studies across many European countries as well as the United States.</p>